Nurix Therapeutics, Inc. NRIX Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Nurix Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The official record: Nurix Therapeutics, Inc.’s 10-Q, filed April 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nurix Therapeutics, Inc.'s total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nurix Therapeutics, Inc.'s total equity?
- Nurix Therapeutics, Inc. (NRIX) reported total equity of $480.89M in Q4 2025.
- How has Nurix Therapeutics, Inc.'s total equity changed year-over-year?
- Nurix Therapeutics, Inc.'s total equity decreased by 0.0% year-over-year, from $480.92M to $480.89M.
- What is the long-term trend for Nurix Therapeutics, Inc.'s total equity?
- Over 5 years (2020 to 2025), Nurix Therapeutics, Inc.'s total equity has grown at a 13.2% compound annual growth rate (CAGR), from $290.27M to $538.75M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.